STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer

Clinical trial NCT07213570 · RECRUITING

Trial details

NCT number: NCT07213570
Sponsor: National Cancer Institute, Naples
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2025-10-16
Primary completion: 2026-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.